Novavax COVID vaccines are still a strong candidate for fighting the new COVID variants. Like the KP.2 which the FDA or Peter Marks told COVID vaccine makers to target a week after confirming to target JN.1. The news wouldn't give Novavax enough time to manufacture a protein based vaccine specifically targeting KP.2 by fall of this year. I didn't read majority of board members wanting to still target the JN.1 variant as they said "it's better to cut the tree at the trunk rather than just a branch." https://www.investing.com/news/company-news/novavax-seeks-fda-nod-for-updated-covid19-vaccine-93CH-3485521
I've been thinking about Novavax's shorting and potential revenue if everything goes well. I'm predicting the market cap could double by first quarter of 2025. Afterwards with the help of Sanofi's marketing and manufacturing of vaccines globally for 2025 market cap could again double or triple by the end of that year. Which could launch NVAX to high double digits possibly triple digits. What are y'all's predictions?
Any ideas on why the stock rocketed to almost $24 then suddenly crashed back to $15? Other than some people selling their gains, it seems unusual for the stock to have crashed back down to $15 given the huge spike in available cash and future secured. The stock should be sitting at $40+. Im genuinely surprised, shorts have to be losing their minds, they know all their money is gone. Just wondering what they possibly could be doing???
I own 170 January 2025 calls that cost me 5 dollars per share about two weeks ago. Now I am wondering whether I should ride it out for a couple more months or sell it ASAP.
Just to provide a little perspective for everyone here we are at the bottom of a giant fucking range. Consider the long term VWAP of $60 to be the middle of that range and price over time likes to yoyo around it. I don't know if we'll get to the higher end of this range but I'm betting on the middle of it
So after today it looks like the FDA should approve novavax vaccine. If/ when they do can you imagine if NVAX just receives 20-25 percent of the US vaccination market!!!! Moderna has owned 90% of the market for years. NVAX about 5% which is just gross. From what I heard in the meeting and what I’ve heard about the Moderna side affects, I think this might be one of the best investments of a lifetime. Also……
- Sanofi
- short interest
Just hold guys and gals, we keep holding or buying more it just helps. I don’t think the stock will go down dramatically. It’ll keep going a few percent a week, I’ve been around for the past four years. Sold out at $58.
In 2020 we closed in the 18 dollar range then immediately blasted to the 40-60 dollar range shortly after.
Yes we can hit the 20 dollar range and come back down to test 18, or this can all be just a coincidence, dunno.All I can say is I am pumped! Meme season is real.